Resonance Specialities logo

Resonance Specialities

RESONANCESPECIALTIESLTD NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹196 Cr
Volatility
Moderate
P/E Ratio
13.6
EBITDA
₹15.60 Cr
Return on Equity
14.19%
Debt to Equity
0.03
Book Value
₹60.28
EPS
₹2.71
52W High
₹188.5
52W Low
₹77

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 83.3 to 56.2 days.

Weaknesses

2
  • Stock is trading at 2.64 times its book value
  • Company has a low return on equity of 10.9% over last 3 years.

Growth Rate

Revenue Growth
16.62% higher than 3Y
Net Income Growth
57.58% higher than 3Y
Cash Flow Change
787% higher than 3Y
ROE
38.3% higher than 3Y
ROCE
38.09% lower than 3Y
EBITDA Margin (Avg.)
15.93% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
13.46
10.14
15.34
16.36
17.3
18.06
18.24
24.2
21.27
21.53
22.96
24.48
32.58
Expenses
11.87
9.22
14.02
15.31
15.22
15.71
16.35
19.95
18.72
19.17
19.51
18.84
25.12
Operating Profit
1.59
0.92
1.32
1.05
2.08
2.35
1.89
4.25
2.55
2.36
3.45
5.64
7.46
OPM %
11.81%
9.07%
8.6%
6.42%
12.02%
13.01%
10.36%
17.56%
11.99%
10.96%
15.03%
23.04%
22.9%
Other Income
0.14
0.25
0.25
0.29
-0.64
0.45
0.3
0.07
0.23
0.35
0.32
0.74
0.54
Interest
0.07
0.09
0.11
0.12
0.1
0.1
0.08
0.03
0.08
0.06
0.05
0.05
0.01
Depreciation
0.35
0.36
0.38
0.37
0.48
0.49
0.48
0.11
0.33
0.33
0.34
0.34
0.34
PBT
1.31
0.72
1.08
0.85
0.86
2.21
1.63
4.18
2.37
2.32
3.38
5.99
7.65
Tax %
33.59%
36.11%
11.11%
21.18%
31.4%
18.1%
31.9%
26.79%
31.22%
28.88%
26.04%
23.37%
24.97%
Net Profit
0.87
0.46
0.96
0.67
0.59
1.81
1.12
3.06
1.63
1.66
2.51
4.6
5.74
EPS in Rs
0.75
0.4
0.83
0.58
0.51
1.57
0.97
2.65
1.41
1.44
2.17
3.98
4.97
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
38
39
34
36
41
56
70
76
58
55
78
90
102
Expenses
37
36
32
35
37
48
56
59
51
50
67
76
83
Operating Profit
1
3
2
1
5
8
14
17
7
5
11
14
19
OPM %
3.3%
8%
6%
1.8%
12%
14%
20%
22%
12%
9%
14%
16%
19%
Other Income
2
0
1
1
1
0
2
1
2
1
0
2
2
Interest
1
1
0
1
1
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
2
1
1
2
1
1
PBT
1
2
1
0
5
7
15
16
7
4
9
14
19
Tax %
7%
28%
26%
2700%
33%
20%
28%
24%
27%
25%
26%
26%
—
Net Profit
1
1
1
-1
3
6
11
12
5
3
7
10
15
EPS in Rs
1.11
1.03
0.89
-0.67
2.77
4.77
9.11
10.71
4.33
2.57
5.69
9.01
12.56
Div. Payout %
45%
0%
0%
0%
0%
21%
11%
9%
23%
0%
18%
11%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12
12
12
12
12
12
12
12
12
12
12
12
Reserves
10
11
12
12
15
19
29
40
44
46
52
62
Borrowings
3
2
4
3
0
0
1
0
2
4
3
2
Other Liabilities
10
8
12
10
12
11
13
5
8
12
8
17
Total Liabilities
35
32
40
37
38
41
55
57
66
74
76
92
Fixed Assets
14
14
15
15
14
14
16
14
20
23
21
21
CWIP
0
0
0
1
1
2
0
0
0
0
1
4
Investments
0
0
0
0
0
0
1
0
0
3
0
12
Other Assets
20
18
25
22
23
25
38
42
45
48
54
57
Total Assets
35
32
40
37
38
41
55
57
66
74
76
92
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
3
1
2
5
1
4
13
-8
4
-3
17
Investing
0
-1
-3
-1
0
-2
-1
-9
3
-7
4
-15
Financing
-2
-2
2
-1
-4
1
0
-2
1
0
-1
-2
Net Cash Flow
-1
0
0
0
1
1
3
3
-4
-2
0
0
Free Cash Flow
1
2
-2
1
5
-1
3
13
-16
0
-4
14
CFO/OP
103
122
28
362
107
47
61
110
-93
117
-5
141
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
99
66
80
68
67
40
49
40
78
89
105
56
Inventory Days
134
159
397
212
180
232
236
176
646
341
316
319
Days Payable
116
108
262
127
139
114
121
17
138
134
65
113
Cash Conversion Cycle
117
117
215
152
108
158
164
198
587
295
356
263
Working Capital Days
71
74
85
80
93
82
99
143
212
221
206
156
ROCE %
4%
9%
7%
2%
20%
31%
41%
35%
13%
7%
15%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Resonance Specialities insights

62 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

FIIs0.03%Promot.54.25%DIIs1.55%Others9.99%Public34.19%As ofJun 2026

Documents

Frequently Asked Questions about Resonance Specialities

What does Resonance Specialities Ltd do?
Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same[1]
Where is Resonance Specialities Ltd (524218) listed?
Resonance Specialities Ltd trades as RESONANCESPECIALTIESLTD on the NSE and under code RESONANCE on the BSE.
Which sector does Resonance Specialities Ltd belong to?
Resonance Specialities Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Resonance Specialities Ltd?
Resonance Specialities Ltd has a market capitalisation of ₹195.98 Cr, which places it in the Small Cap band.
What is the PE ratio of Resonance Specialities Ltd?
Resonance Specialities Ltd trades at a PE ratio of 13.60, on earnings per share of ₹2.71, against a book value of ₹60.28 per share.
What is the 52-week high and low of Resonance Specialities Ltd?
Over the last 52 weeks Resonance Specialities Ltd has traded between ₹77 and ₹188.5.
Does Resonance Specialities Ltd pay dividends?
Resonance Specialities Ltd has a dividend yield of 0.58%.
What is the Return on Equity (ROE) of Resonance Specialities Ltd?
Resonance Specialities Ltd reported a return on equity of 14.19%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 1989, Resonance Specialties Ltd manufactures Pyridine, Picoline, Cynopyridine and derivatives of the same[1]

Website resonancesl.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524218.md for Resonance Specialities Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List